aTyr Pharma Inc. (LIFE)

3.86
NASDAQ : Health Technology
Prev Close 3.93
Day Low/High 3.82 / 3.98
52 Wk Low/High 2.76 / 12.33
Avg Volume 195.60K
Exchange NASDAQ
Shares Outstanding 3.89M
Market Cap 15.29M
EPS -16.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ATyr Pharma Announces Second Quarter 2019 Results And Provides Corporate Update

ATyr Pharma Announces Second Quarter 2019 Results And Provides Corporate Update

aTyr to report interim safety results from Phase 1b/2a proof-of-concept trial of ATYR1923 in pulmonary sarcoidosis patients in Q4 2019 Company to host conference call and webcast today, August 14, at 5:00pm EDT SAN DIEGO, Aug.

ATyr Pharma To Announce Second Quarter 2019 Results On August 14th

ATyr Pharma To Announce Second Quarter 2019 Results On August 14th

Company to host conference call and webcast at 5pm EDT / 2pm PDT

Leading Immunobiology Researcher Dr. David Briscoe Joins ATyr Pharma As Scientific Advisor

Leading Immunobiology Researcher Dr. David Briscoe Joins ATyr Pharma As Scientific Advisor

Dr. Briscoe to advise company on ongoing development of therapeutics based on the Neuropilin-2 (NRP2) co-receptor and related signaling pathways

Evolve Announces July 2019 Distributions For Evolve ETFs

Evolve Announces July 2019 Distributions For Evolve ETFs

TORONTO, July 24, 2019 /CNW/ - Evolve Funds Group Inc. ("Evolve") is pleased to announce the distribution amounts per unit (the "Distributions") for certain exchange traded funds (the "Evolve ETFs") for the period ending July 31, 2019, as indicated in the...

ATyr Pharma To Host Key Opinion Leader Call And Webcast On Sarcoidosis And The Current Treatment Landscape

ATyr Pharma To Host Key Opinion Leader Call And Webcast On Sarcoidosis And The Current Treatment Landscape

Conference Call Scheduled for Thursday, July 18th @ 2pm Eastern/11am Pacific

ATyr Pharma Announces Fourth Quarter And Year-End 2017 Operating Results And Provides Corporate Update

ATyr Pharma Announces Fourth Quarter And Year-End 2017 Operating Results And Provides Corporate Update

- Conference Call Today at 2:00 p.m. PT / 5:00 p.m. ET -

ATyr Pharma Announces Poster Presentation At ASCO-SITC Clinical Immuno-Oncology Symposium    

ATyr Pharma Announces Poster Presentation At ASCO-SITC Clinical Immuno-Oncology Symposium    

aTyr's ORCA program on-track to enter the clinic in 2019

7 Stocks Under $10 Making Big Moves Higher

7 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.